Anna Berkenblit, Chief Scientific and Medical Officer at Pancreatic Cancer Action Network, shared Pancreatic Cancer Action Network’s post on LinkedIn, adding:
“Deeply appreciative of our industry partners whose collaboration helps accelerate research and advance meaningful progress for patients with pancreatic cancer.”
Pancreatic Cancer Action Network shared a post on LinkedIn:
“Our Industry supporters work tirelessly to create a brighter future for patients with pancreatic cancer. We are grateful for their generous support.
Visit to read the 2025 PanCAN Impact Report, Spotlight on Progress.”
More posts about Pancreatic Cancer.